ClinConnect ClinConnect Logo
Search / Trial NCT06913166

Effectiveness of an Online Quiz in Promoting Tobacco-Related Knowledge, Attitudes, and Behaviours Among Primary Students

Launched by THE UNIVERSITY OF HONG KONG · Mar 29, 2025

Trial Information

Current as of September 09, 2025

Recruiting

Keywords

Tobacco Cessation Literacy Non Pharmaceutical Intervention Adolescents

ClinConnect Summary

This clinical trial is looking at how an online quiz can help primary school students learn more about the dangers of tobacco and smoking. The main goal is to see if participating in this quiz can improve their knowledge about tobacco, change their attitudes towards smoking, and lower their intention to start smoking. The researchers will compare the quiz answers of students who take part in the online quiz with those who do not, to see if there’s a difference in what they know and how they feel about tobacco.

To be eligible for this study, students must be in Primary 5 or 6 at a local school, be able to read and communicate in Chinese, and have access to a digital device at home to complete the quiz. There are no specific exclusions for this trial. If your child participates, they can expect to engage in a fun and interactive quiz that aims to educate them about tobacco and promote healthier choices. This is an important step in helping young people understand the risks associated with smoking and alternative tobacco products.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Primary 5-6 students from local primary schools
  • Able to read and communicate in Chinese
  • Have a digital device for online access to the quiz game at home
  • Exclusion Criteria:
  • None

About The University Of Hong Kong

The University of Hong Kong (HKU) is a leading research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, HKU collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous and ethically sound clinical studies. The university's diverse expertise and state-of-the-art facilities enable it to explore a wide range of therapeutic areas, contributing to the global pursuit of scientific advancement and the development of novel treatment strategies.

Locations

Hong Kong, Hong Kong

Patients applied

0 patients applied

Trial Officials

Shiu Lun Ryan Au Yeung

Principal Investigator

School of Public Health, The University of Hong Kong

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported